Rare diseases
Investigational molecules
Locations
Back to Poland302 clinical trials in Olsztyn, Poland across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)PolandRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
PolandPolandA Phase 3 Randomized Study of mRNA‑4157 plus Pembrolizumab as Adjuvant Therapy in Patients with Completely Resected Stage I Non‑Small Cell Lung Cancer
PolandOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
PolandLong-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
PolandA study to evaluate the safety and how the body uses ublituximab injections in patients with multiple sclerosis
PolandA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
PolandA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
PolandStudy of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer
PolandLong-term safety study of deucravacitinib compared to ustekinumab in adults with moderate to severe plaque psoriasis
PolandA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
PolandThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on acute myeloid leukemia treatments and innovative therapies for various types of lung cancer. Studies include evaluation of new drug combinations and treatment approaches for colorectal cancer and lymphoma.
Research emphasizes personalized medicine approaches and improving patient outcomes in advanced stages of disease.
Innovative research into plaque psoriasis and psoriatic arthritis treatments, including new biological therapies and novel drug combinations. Studies also examine treatments for rare conditions like pyoderma gangrenosum.
Focus on developing more effective treatments for moderate to severe skin conditions.
Studies examining new approaches to heart failure prevention and treatment, including investigations of novel drug combinations. Research focuses on reducing cardiovascular events and improving outcomes in high-risk patients.
Emphasis on preventive measures and innovative treatment strategies for cardiac conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
